Seoul National University SNU R&DB Foundation
VC Fund
Seoul National University SNU R&DB Foundation is a VC fund focused on Biotechnology and Software. Seoul National University Technology Holdings offers investment services.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 79%
Last updated:
For AI agents: llms.txt
Industries Seoul National University SNU R&DB Foundation invests in
Stages Seoul National University SNU R&DB Foundation invests in
Countries Seoul National University SNU R&DB Foundation invests in
Round sizes
Round size
- Seed
- $145k–$3.5M
Investment Focus
Industry
- Biotechnology 4 (29%)
- Software 3 (21%)
- Health Care 3 (21%)
- B2B 2 (14%)
- SaaS 2 (14%)
Stage
- Seed 10 (71%)
- Series A 1 (7%)
- Funding Round 1 (7%)
Country
- South Korea 10 (71%)
- United States 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| LTIS designs and sells fluid imaging cytometers to laboratories and enterprises, focusing on advanced imaging technologies for analysis. | Seed / Jul 08, 2024 | ||
| Liberty Labs specializes in prompt engineering that allows them to build applications that showcase AI potential. Liberty Labs offers products such as Toolbuilder, regex.ai, Opencharacter, and CLN.me. | Seed / May 09, 2024 | ||
| Dreampack offers medical treatments to assist patients with terminal cancer. | Seed / May 09, 2024 | ||
| SILI Energy manufactures silicon/lithium materials such as solid-state batteries for electric cars. | Seed / May 07, 2024 | ||
Molecular Innovations
|
Molecular Innovations creates novel compounds, determining their efficacy and properties. Molecular Innovations is a technology-based startup founded with the goal of developing new drugs and cosmetic ingredients based on the discovery of the novel substance resveratron at the laboratory of the Department of Chemistry at Seoul National University.Resveratron is a previously non-existent low-molecular-weight substance created by modifying resveratrol, which is used as an ingredient in health supplements and cosmetics due to its antioxidant properties and efficacy in cardiovascular protection, anticancer, and anti-inflammatory effects. | $145.1K / Seed / Apr 26, 2024 | |
AptaMarket
|
AptaMarket offers high-precision pancreatic cancer testing kits and treatments. | Seed / Feb 22, 2024 | |
Proba Labs
|
Proba Labs develops biological function chips to enhance preclinical-stage drug efficacy and toxicity testing equipment. | Seed / Feb 05, 2024 | |
| Coxwave, founded in 2021, is a leader in analytics for the generative AI industry. Leveraging state-of-the-art data infrastructure and domain expertise, our team operates Align AI, powering analytics for conversational AI products. Coxwave successfully raised a $3.5M seed round led by KB Investment to double down on efforts to support global AIbuilders and increase R&D in new analytics technology.Align AI is a next-generation product analytics tool for LLM-powered conversational AI products. Leveraging Align AI’s cutting-edge natural language search and robust analytics infrastructure, product builders can easily analyze conversational data to make informed product decisions. | $3.5M / Seed / Jan 29, 2024 | ||
| Coxwave provides product analytics and observability for AI applications. The Skylight platform instruments LLM prompts, responses, context, and user interactions via SDKs and ingestion APIs. It aggregates metrics such as quality, latency, token usage, and cost, and presents dashboards to monitor trends and detect regressions. Teams use it tocollect human feedback, build evaluation datasets, and compare prompt or model variants before and after releases. Tracing links events across sessions and workflows, helping correlate outcomes with inputs and application state. Integrations connect to common LLM providers, orchestration frameworks, and data pipelines, allowing data to flow into existing analytics stacks and workflows. | $3.5M / Seed / Jan 29, 2024 | ||
| GeneCraft specializes on improving treatment and clinical outcomes for patients using gene therapy. | $7.6M / Series A / Jan 15, 2024 | ||
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Seoul National University SNU R&DB Foundation invest in?
Seoul National University SNU R&DB Foundation invests primarily in Biotechnology, Software and Health Care startups, most often at Seed and Series A stage. Most of the 14 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Seoul National University SNU R&DB Foundation invest in?
Seoul National University SNU R&DB Foundation typically joins rounds of $145k–$3.5M at Seed. These are whole funding-round sizes, not Seoul National University SNU R&DB Foundation's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Seoul National University SNU R&DB Foundation took part in.
When did Seoul National University SNU R&DB Foundation last invest?
The most recent investment recorded for Seoul National University SNU R&DB Foundation closed in Jul 2024. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
